儿科实践中的家族性高胆固醇血症

Q3 Medicine
Y. Zaripova, O. L. Igo, E.G. Mikhaylovskaya, N. B. Guseva, S. S. Nikitin, M. A. Mushkatina, T. Varlamova, V. Korneva
{"title":"儿科实践中的家族性高胆固醇血症","authors":"Y. Zaripova, O. L. Igo, E.G. Mikhaylovskaya, N. B. Guseva, S. S. Nikitin, M. A. Mushkatina, T. Varlamova, V. Korneva","doi":"10.20953/1817-7646-2023-3-127-132","DOIUrl":null,"url":null,"abstract":"Familial hypercholesterolemia (FH) is a hereditary disease characterized by elevated levels of low-density lipoproteins, early onset and progressive course of atherosclerosis (usually at a young age), and high risk of cardiovascular complications. Detection of mutations in family members enables the diagnosis of FH. However, approximately 20% of FH patients are tested negative for the FH-associated mutations. This results in a delayed diagnosis and late therapy initiation, especially in children. Therefore, raising awareness about FH both among healthcare professionals and in the society is very important. Key words: children, lipid-lowering therapy, familial hypercholesterolemia, screening, registry","PeriodicalId":38157,"journal":{"name":"Voprosy Prakticheskoi Pediatrii","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Familial hypercholesterolemia in pediatric practice\",\"authors\":\"Y. Zaripova, O. L. Igo, E.G. Mikhaylovskaya, N. B. Guseva, S. S. Nikitin, M. A. Mushkatina, T. Varlamova, V. Korneva\",\"doi\":\"10.20953/1817-7646-2023-3-127-132\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Familial hypercholesterolemia (FH) is a hereditary disease characterized by elevated levels of low-density lipoproteins, early onset and progressive course of atherosclerosis (usually at a young age), and high risk of cardiovascular complications. Detection of mutations in family members enables the diagnosis of FH. However, approximately 20% of FH patients are tested negative for the FH-associated mutations. This results in a delayed diagnosis and late therapy initiation, especially in children. Therefore, raising awareness about FH both among healthcare professionals and in the society is very important. Key words: children, lipid-lowering therapy, familial hypercholesterolemia, screening, registry\",\"PeriodicalId\":38157,\"journal\":{\"name\":\"Voprosy Prakticheskoi Pediatrii\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Voprosy Prakticheskoi Pediatrii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20953/1817-7646-2023-3-127-132\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Voprosy Prakticheskoi Pediatrii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20953/1817-7646-2023-3-127-132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

家族性高胆固醇血症(FH)是一种遗传性疾病,其特征是低密度脂蛋白水平升高、动脉粥样硬化早发和进行性病程(通常在年轻时)以及心血管并发症的高风险。检测家庭成员中的突变有助于诊断FH。然而,大约20%的FH患者的FH相关突变检测呈阴性。这导致诊断延迟和治疗开始晚,特别是在儿童中。因此,提高卫生保健专业人员和社会对FH的认识是非常重要的。关键词:儿童;降脂治疗;家族性高胆固醇血症
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Familial hypercholesterolemia in pediatric practice
Familial hypercholesterolemia (FH) is a hereditary disease characterized by elevated levels of low-density lipoproteins, early onset and progressive course of atherosclerosis (usually at a young age), and high risk of cardiovascular complications. Detection of mutations in family members enables the diagnosis of FH. However, approximately 20% of FH patients are tested negative for the FH-associated mutations. This results in a delayed diagnosis and late therapy initiation, especially in children. Therefore, raising awareness about FH both among healthcare professionals and in the society is very important. Key words: children, lipid-lowering therapy, familial hypercholesterolemia, screening, registry
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Voprosy Prakticheskoi Pediatrii
Voprosy Prakticheskoi Pediatrii Medicine-Pediatrics, Perinatology and Child Health
CiteScore
1.20
自引率
0.00%
发文量
50
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信